Strategies to Reduce Health Disparities and Improve Outcomes in Breast and Prostate Cancer

The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of breast and prostate cancer in Black patients.

NCCN Guidelines® Updates: Breast Cancer - Treatment of Hormone-Sensitive Advanced Breast Cancer

This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.

CDK4/6 Inhibition in Breast Cancer: Expert Perspectives on Integrating Guideline Updates and Recent Advances Into Practice
Experts discuss the latest clinical data and evolving role of CDK4/6 inhibitors in breast cancer across disease stages and explore emerging therapies, biomarker-driven approaches, and considerations for individualizing patient care in this certified on-demand webcast.
New Tools for Breast Cancer Risk Assessment
It is important for clinicians to learn about these risk assessment models, understand their limitations and benefits, and determine the best breast cancer risk reduction strategy that can be used for an individual.
CDK4/6 Inhibition in Breast Cancer: Expert Perspectives on Integrating Guideline Updates and Recent Advances Into Practice
Join us for this engaging session led by expert oncology faculty to learn the latest evidence and recommendations with CDK4/6 inhibitors for breast cancer. Insights on how to best mitigate CDK4/6 inhibitor–related adverse events will also be highlighted.
Survivorship Care for Patients Living with Metastatic Breast Cancer

The population of survivors living long-term with incurable breast cancer has grown rapidly, and clinicians may not be aware of how to manage the many unique issues and needs faced by this population.

Inequities in Clinical Outcomes in Breast Cancer: Do Biologic Differences Based on Ancestry/Racial Identity Play a Role?

The treatment landscape for breast cancer has shifted dramatically over the last several decades and, despite the increasing incidence of breast cancer, overall survival rates continue to improve.

Advances in the Management of Metastatic Breast Cancer with SABCS Updates

The decision-making process for management of metastatic breast cancer should involve careful consideration of the available evidence for selection of optimal therapy and a detailed discussion with patients of the benefits and risks associated with all possible treatment strategies.

Management of CNS Metastases in Patients with Breast Cancer

Advances in diagnosis and treatment have increased the survival of patients with advanced breast cancer; however, longevity is associated with an increased detection of brain metastases in these individuals.

Surgical Management of DCIS and Invasive Breast Cancer with SABCS Updates

There is a growing emphasis on individualizing surgical treatment based on patient and tumor specific factors.

Pages

Subscribe to RSS - Breast Cancer